Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chiara Saggia
Eribulin in Pretreated Metastatic Breast Cancer Patients: Results of the TROTTER Trial—a Multicenter Retrospective Study of Eribulin in Real Life
SpringerPlus
Multidisciplinary
HER2-positive Breast Cancer With Brain Metastasis, Long Responder to Lapatinib Therapy
AboutOpen
Related publications
Eribulin Mesylate in the Treatment of Metastatic Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Eribulin Suppresses New Metastases in Patients With Metastatic Breast Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Real-World Efficacy and Safety of Eribulin in Advanced and Pretreated HER2-negative Breast Cancer in a Spanish Comprehensive Cancer Center
BMC pharmacology & toxicology
Medicine
Pharmacology
Outcome of Eribulin as a Late Treatment Line for Thai Metastatic Breast Cancer Patients
OncoTargets and Therapy
Oncology
Pharmacology
Analysis of Eribulin Mesylate Dosing Modifications Impact on Administration Persistence in Patients With Metastatic Breast Cancer (Mbc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Use of Eribulin as an Earlier-Line Chemotherapy for Patients With HER2-negative Metastatic Breast Cancer
Journal of Cancer
Oncology
Eribulin for the Treatment of Metastatic Breast Cancer: An Update on Its Safety and Efficacy
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
Resolution of the Advisory Board “Prospects for Study and Use of Eribulin in Advanced Breast Cancer”
Malignant tumours